Roth Capital Initiates Coverage On BioHarvest Sciences with Buy Rating, Announces Price Target of $10
Benzinga Newsdesk 8 months ago
NewsPrice TargetInitiationAnalyst Ratings
Roth Capital analyst Sean McGowan initiates coverage on BioHarvest Sciences (NASDAQ:BHST) with a Buy rating and announces Price Target of $10.
Roth Capital analyst Sean McGowan initiates coverage on BioHarvest Sciences (NASDAQ:BHST) with a Buy rating and announces Price Target of $10.